Rheumatoid Arthritis Studies

Credit: CDC

NIAID is committed to advancing the understanding of how and why autoimmune diseases such as rheumatoid arthritis occur. Your participation in our clinical research studies can help develop more effective treatment approaches and prevention strategies.

The following clinical trial is sponsored by NIAID and is recruiting people with rheumatoid arthritis. The link leads to a detailed description, eligibility requirements, and contacts and locations:

Strategy to Prevent the Onset of Clinically-Apparent Rheumatoid Arthritis (StopRA) (NCT02603146)
The purpose of this study is to determine if hydroxychloroquine (HCQ) is safe and effective for the prevention of future onset of rheumatoid arthritis (RA) in individuals who have elevations of an autoantibody, anti-cyclic citrullinated peptide (anti-CCP).

Read about NIAID research on autoimmune diseases.

Participating in Research

Watch a series of short informational videos about participating in clinical trials. These videos are intended to help potential participants understand how research works, what questions they should consider asking, and things to think about when deciding whether or not to participate in a study.

Content last reviewed on